Does Dr. RAGHAV GOVINDARAJAN have financial conflicts of interest?

Dr. RAGHAV GOVINDARAJAN (MD) has received a total of $732,580 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $732,580 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RAGHAV GOVINDARAJAN?

According to CMS Open Payments data, Dr. RAGHAV GOVINDARAJAN received funding from ARGENX US ($198,509), ALEXION PHARMACEUTICALS ($127,928), and UCB ($76,021).

Does Dr. RAGHAV GOVINDARAJAN receive research grants or speaking fees?

Dr. RAGHAV GOVINDARAJAN has received $732,580 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RAGHAV GOVINDARAJAN

MDReal-Time Hydrated

Specialty: Psychiatry & Neurology, Neuromuscular Medicine

Practice Location: O FALLON, IL 62269

NPI Number: 1639481914

LIFETIME INDUSTRY VALUE

$732,580

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. GOVINDARAJAN is a verified Psychiatry & Neurology, Neuromuscular Medicine practitioner based in O FALLON, IL.

Between 2021 and 2025, Dr. GOVINDARAJAN had an overall industry promotional and research financial footprint of $732,580 as recorded in the federal CMS Open Payments database.

$732,580 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. GOVINDARAJAN's primary funding source is ARGENX US, which accounts for $198,509 (representing 27.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ARGENX US

Rank 1

$198,509

27.1%

ALEXION PHARMACEUTICALS

Rank 2

$127,928

17.5%

UCB

Rank 3

$76,021

10.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.